Phlow
RICHMOND, Virginia, United States · Biotechnology, Health Care, Manufacturing
Phlow, a B Corporation™, helps brilliant minds bring medicines to life through advanced development and manufacturing in America. Focused on innovations in drug substance development, Phlow supports government and private industry customers to create innovative approaches with scientific expertise, world-class manufacturing, and tech-enabled processes that propel the industry forward to a new stan
Key facts
- Headquarters
- RICHMOND, Virginia, United States
- Employees
- 106
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- phlow.com
- Company page
Recent activity at Phlow
- : Phlow Corp. Appoints Sripathy Venkatraman as Chief Scientific Officer
- : Phlow Corp. closes $37M Series C financing round led by Align Private Capital to enhance medicine development and manufacturing in America.
- : Phlow
- : Phlow
- : Phlow Announces Over $35M In Series B Funding To Improve The U.S. Medicine Supply Chain
- : Phlow
- : Phlow Corp.
Phlow funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Series C | $37.0M |
| Feb 2025 | Venture | $30.5M |
| Jul 2024 | Venture | $5.0M |
| Apr 2023 | Series B | $35.0M |
| Sep 2022 | Venture | $24.2M |
Leadership
- Eric Edwards, Director
- Sripathy Venkatraman, Chief Scientific Officer
- David Ryan, Chief Financial Officer
Verified email and direct lines for Phlow’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Phlow files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Phlow in the news
- Fresenius Kabi, Phlow ink US onshoring alliance to boost epinephrine injection supply - Fierce Pharma (Feb 09, 2026)
- HHS leaders visit Phlow Corp. campus to see pharmaceuticals made from start to finish | AHA News - American Hospital Association (Jul 10, 2025)
- Trump-era federal Covid contract recipient has yet to meet major deadlines - Politico (Jul 09, 2022)
- Phlow founding CEO Eric Edwards steps down; replacement named - Richmond BizSense (May 26, 2026)
- Trump administration taps startup to build stockpile of key drug ingredients - NBC News (May 18, 2020)
- VCU’s Medicines for All Institute partners with industry to secure the domestic pharmaceutical supply chain - VCU News (May 19, 2020)
- America’s Hidden Battlefield: The $96 Billion Drug Supply Chain Wake-Up Call - BioBuzz (Sep 07, 2025)
- Trump to Tap New Company to Make Covid-19 Drugs in the U.S. (Published 2020) - The New York Times (May 18, 2020)
Companies similar to Phlow
- Parnell · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- Helus Pharma · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- Paladin Pharma · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- USpharma Ltd · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- Ionetix Corp · Biotechnology, Health Care, Manufacturing, Pharmaceutical
About Phlow: questions and answers
What does Phlow do?
Phlow, a B Corporation™, helps brilliant minds bring medicines to life through advanced development and manufacturing in America. Focused on innovations in drug substance development, Phlow supports government and private industry customers to create innovative approaches with scientific expertise, world-class manufacturing, and tech-enabled processes that propel the industry forward to a new stan
Where is Phlow headquartered?
Phlow is headquartered in RICHMOND, Virginia, United States.
How many employees does Phlow have?
Phlow has about 106 employees.
Has Phlow raised funding?
Yes. Fundz has recorded 5 funding events for Phlow. The most recent, Series C of $37.0M, was in Jul 2025.
What is the latest news on Phlow?
On Jul 22, 2026, Phlow Corp. Appoints Sripathy Venkatraman as Chief Scientific Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy